Value-based care commitment increasing

More than 2,800 payers, providers, employers, patients, states, consumer groups, employers and others have agreed to join the Health Care Payment Learning and Action Network.

The Department of Health and Human Services (HHS) created the program to test alternative payment models. HHS Secretary Sylvia Burwell recently announced the government’s goal of tying 30 percent of payments to quality and value by 2016 and 50 percent by 2018.

HHS provided several examples of organizations committed to payment reform. For instance, Caesars Entertainment launched a bundled payment demonstration model for non-emergent surgical procedures such as hip and knee replacements.

In addition, Cigna has agreed to tie 90 percent of its payments in value-based arrangements and 50 percent of payments in alternative payment models by 2018.

Further, Dignity Health plans to move 50 percent of its payments to accountable care by 2018 and 75 percent by 2020, while Rite Aid is working with its benefit administrators to have more than 50 percent of its spending through alternative models by 2018.

The state of Delaware has committed to have 80 percent of its residents receive care through value-based payments within five years.

The American College of Physicians will also educate its 141,000 members on patient-centered medical homes, accountable care organizations and other alternative payment models.

Read the HHS news release here.

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.